FOLR1 and non-small cell lung carcinoma: Several other ADCs targeting molecules such as EGFR, folate receptor 1 (FOLR1), receptor tyrosine kinase-like orphan receptor 2 (ROR2) and AXL receptor tyrosine kinase (AXL) are currently under investigation for the treatment of NSCLC, but data on intracranial activity are not yet available (Table A1).